# Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference

- Source: PR Newswire M&A
- Published: 2026-11-02T21:15:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-healthcare-innovation-conference-302926829.html
- Canonical: https://groundlevelnews.com/story/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-healthca-01eb54/

ARLINGTON, Mass., Nov. 2, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases, today announced that Sumit Aggarwal, President and Chief Executive Officer, will present at...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._